Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: Impact on functional activity and selectivity for dopamine D2/D3 receptors

作者: Bhaskar Gopishetty , Suhong Zhang , Prashant S. Kharkar , Tamara Antonio , Maarten Reith

DOI: 10.1016/J.BMC.2013.03.059

关键词: Partial agonistChemistryImidazoleAgonistStructure–activity relationshipAmideMoietyStereochemistryRadioligandRadioligand AssayOrganic chemistryClinical biochemistryMolecular medicineBiochemistryMolecular biologyDrug discoveryPharmaceutical Science

摘要: The goal of the present study was to explore, in our previously developed hybrid template, effect introduction additional heterocyclic rings (mimicking catechol hydroxyl groups as bioisosteric replacement) on selectivity and affinity for D3 versus D2 receptor. In addition, we wanted explore derivatization functional agonist binding moiety compounds by us earlier from template. Binding (K(i)) new measured with tritiated spiperone radioligand HEK-293 cells expressing either or receptors. Functional activity selected assessed GTPγS assay. imidazole series, compound 10a exhibited highest whereas indole derivative 13 similar high affinity. Functionalization amino group (+)-9d different sulfonamides derivatives improved significantly (+)-14f exhibiting However, functionalization 15 (+)-9d, known partial agonist, sulfonate ester amide general modulated both cases loss potency resulted such derivatization.

参考文章(36)
CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON, MOHAMED JABER, MARC G. CARON, Dopamine Receptors: From Structure to Function Physiological Reviews. ,vol. 78, pp. 189- 225 ,(1998) , 10.1152/PHYSREV.1998.78.1.189
Pierre Sokoloff, Bruno Giros, Marie-Pascale Martres, Marie-Louise Bouthenet, Jean-Charles Schwartz, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. ,vol. 347, pp. 146- 151 ,(1990) , 10.1038/347146A0
Aloke K Dutta, Sylesh K Venkataraman, Xiang-Shu Fei, Rohit Kolhatkar, Shijun Zhang, Maarten E.A Reith, Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors. Bioorganic & Medicinal Chemistry. ,vol. 12, pp. 4361- 4373 ,(2004) , 10.1016/J.BMC.2004.06.019
V. Šukalović, Deana Andrić, G. Roglić, Sladjana Kostić-Rajačić, A. Schrattenholz, V. Šoškić, Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs European Journal of Medicinal Chemistry. ,vol. 40, pp. 481- 493 ,(2005) , 10.1016/J.EJMECH.2004.10.006
Nana Sartania, Philip G. Strange, Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors. Journal of Neurochemistry. ,vol. 72, pp. 2621- 2624 ,(2002) , 10.1046/J.1471-4159.1999.0722621.X
Yan-Hui Yang, Mao-Sheng Cheng, Qing-He Wang, Han Nie, Na Liao, Jian Wang, Hong Chen, Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles. European Journal of Medicinal Chemistry. ,vol. 44, pp. 1808- 1812 ,(2009) , 10.1016/J.EJMECH.2008.07.021
Swati Biswas, Suhong Zhang, Fernando Fernandez, Balaram Ghosh, Juan Zhen, Eldo Kuzhikandathil, Maarten E. A. Reith, Aloke K. Dutta, Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action. Journal of Medicinal Chemistry. ,vol. 51, pp. 101- 117 ,(2008) , 10.1021/JM070860R
Jeffrey C. Pelletier, Murty Chengalvala, Josh Cottom, Irene Feingold, Lloyd Garrick, Daniel Green, Diane Hauze, Christine Huselton, James Jetter, Wenling Kao, 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Bioorganic & Medicinal Chemistry. ,vol. 16, pp. 6617- 6640 ,(2008) , 10.1016/J.BMC.2008.05.024